Your shortcut for this week:
Read on for the foresight of the week and the full breakdown of what shaped healthcare AI 👇
Solutions and Launches
UpDoc (US): announced FDA clearance for its clinical AI platform, which uses patient-facing large language models to support real-time care coordination and clinician-supervised chronic disease management. [Link]
Aidoc (US): received FDA Breakthrough Device Designation for First Read, an investigational AI tool that analyses chest radiographs and drafts preliminary radiology report text. [Link]
BrightHeart (France): received a CE mark for B-Right, an AI platform that supports prenatal ultrasound with live acquisition guidance and fetal-organ evaluation. [Link]
Cercare Medical (Denmark): received FDA 510(k) clearance for Oncology Virtual Expert, an on-premise AI tool that semi-automates brain tumour segmentation from MRI. [Link]
Xella Health (US): launched an AI-powered women’s precision health platform that uses multi-omic biomarkers and clinical inputs to screen for more than 130 female-specific conditions. [Link]
ProjectLeo (US): launched an AI patient-advocate iOS app that connects to health records and helps patients understand records, prepare for appointments, review bills and appeal insurance denials. [Link]
Governance, Policy, and Ethics
US HHS (US): held a public update on clinical AI, including ARPA-H’s ADVOCATE programme for agentic cardiovascular AI focused first on heart failure. [Link]
Rhode Island (US): enacted three AI laws covering therapy chatbots, self-harm safety protocols and patient notification when AI is used to document clinical visits. [Link]
Research and AI Advancements
Generative-AI clinical decision support in primary care (Kenya): a cluster-randomised trial found an LLM-assisted primary care tool improved documentation and treatment-plan quality, but did not significantly reduce 14-day treatment failure. [Link]
Automated genomic reanalysis for rare disease (Nature Medicine): researchers introduced Talos, an automated tool for rare-disease genome reanalysis that identified new diagnoses in 5.1% of previously undiagnosed cases. [Link]
ECG biomarker for sudden cardiac death: researchers used deep learning on ECG data to identify a biomarker associated with higher risk of sudden cardiac death. [Link]
Partnerships & Adoption
Oracle Health & Theator (US/Israel): partnered to offer Theator’s AI surgical-intelligence system to Oracle Health’s US customers, using operative video to generate structured reports for the EHR. [Link]
UHealth & Avatar Medical (US): began deploying Eonis Vision, a 3D medical-imaging visualisation tool used to show CT and MRI scans during neurosurgery consultations. [Link]
DarioHealth & Beluga Health (US): entered a collaboration combining Dario’s AI-driven triage with Beluga’s 50-state physician network to support care across hypertension, diabetes, obesity, behavioural health and musculoskeletal conditions. [Link]
Doctronic & Simple HealthKit (US): partnered to connect Doctronic’s AI assistant with Simple HealthKit’s at-home testing programs, with follow-up care through Doctronic after results. [Link]
TRIMEDX & OSF HealthCare (US): partnered to use AI-powered clinical-asset analytics, clinical engineering and medical-device cybersecurity across OSF HealthCare. [Link]
Bets on the Next Health System
Investments:
Assort Health (US): raised $120 million in Series C funding led by Menlo Ventures, at a $1.2 billion valuation, to scale its AI agents for patient scheduling, intake, referrals and other patient-journey workflows. [Link]
Trase (US): raised $107 million in seed funding led by ARCH Venture Partners to build agentic AI for regulated industries, including a deployment in Duke Health’s cardiology division. [Link]
xCures (US): raised $46 million in Series B funding led by Innovius Capital to expand its Clinical Clarity Engine, which turns fragmented medical records into decision-ready clinical data. [Link]
Hera (US): raised $27 million in Series A funding led by Bain Capital Ventures to expand its AI-supported senior-care coordination platform. [Link]
M&A:
PsychPlus (US): acquired Koa Health, a London-based digital mental-health company, adding digital therapeutics and a patient-facing app to its technology-enabled mental health platform. [Link]
Withings (France): acquired Biosency, a Rennes-based remote-monitoring company with a certified algorithm for early detection of COPD exacerbations. [Link]
That’s a wrap for Edition #37 of Health AI Foresight.
My goal with this newsletter is simple - to connect the present, the emerging, and the future of healthcare AI.
See you next week.
- Dr. Aboufandi
📩 Something stand out? Or have a suggestion? Hit reply - I read every message.